在多发性骨髓瘤中,BRMS1抑制PI3K/AKT/mTOR通路以调节自
Nueramina Yimingniyazi1, Maimaitiaili Abudureheman2, Wulamujiang Aili1
1Department of Hematology, The First People's Hospital of Kashgar Region, Kashgar, China.
Leukemia & lymphoma
|July 16, 2025
概括
乳腺癌转移抑制剂1 (BRMS1) 在多发性骨髓瘤 (MM) 中起到瘤抑制作用. 它的恢复通过调节自和亡来抑制MM的进展,提供新的治疗途径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 多发性骨髓瘤 (MM) 是一种血液性恶性瘤,其特征是无控制的血细胞增殖.
- 转移抑制剂,如乳腺癌转移抑制剂1 (BRMS1) 在MM病变发生过程中的作用尚不清楚.
- 识别新的瘤抑制剂对于开发有效的MM疗法至关重要.
研究的目的:
- 研究BRMS1在多发性骨髓瘤进展中的作用.
- 阐明BRMS1在MM细胞中的功能背后的分子机制.
- 探索BRMS1作为MM的潜在治疗点.
主要方法:
- 定量实时PCR和西式斑点测试,以评估MM样本和细胞系中的BRMS1表达.
- 在体外功能测试包括细胞增殖,迁移,入侵,亡和自流量测试.
- 自的药理学操纵和PI3K/AKT/mTOR信号通路的研究.
主要成果:
- 在MM患者样本和细胞系中,BRMS1表达显著下调.
- 过度表达BRMS1抑制了MM细胞的增殖,迁移和入侵,同时增强了细胞亡和自流.
- 击败BRMS1促进MM细胞瘤性行为,其瘤抑制作用依赖于通过PI3K/AKT/mTOR通路的自调节.
结论:
- 在多发性髓瘤中,BRMS1作为瘤抑制剂起作用.
- BRMS1通过调节自和亡来调节MM的进展.
- 针对BRMS1介导的自为MM治疗的潜在新疗法策略.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
Interactions Between Signaling Pathways
6.5K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.5K


